Praxbind works by binding to Pradaxa to neutralize its effect (measured as unbound Pradaxa plasma concentration). In one ongoing trial, the anticoagulant effect of Pradaxa was fully reversed in 89% of patients within four hours. In clinical trials, 5gs of Praxbind (idarucizumab) reversed the anticoagulant effect of Pradaxa within minutes (which is significantly faster than the current antidotes for warfarin). Walter Kerwin, MD, Cedars-Sinai Medical Center, Los Angeles, CA Steve Ryan, PhD, provides a comprehensive guide for persons seeking to find a cure for their Atrial Fibrillation.' 'Within the pages of Beat Your A-Fib, Dr. This is not an easy thing to do, but you have been very, very successful at it.' You managed to combine an encyclopedic compilation of information with the simplicity of presentation that enhances the delivery of the information to the reader. She loves it and finds it very useful to help her in dealing with atrial fibrillation.' 'Dear Steve, I saw a patient this morning with your book and highlights throughout. Professor of Cardiology, Haut-Lévêque Hospital, Bordeaux, France I certainly recommend it for patients who want to know more about atrial fibrillation than what they will learn from doctors.' 'This book is incredibly complete and easy-to-understand for anybody. 'If I had 10 years ago, it would have saved me 8 years of hell.” Doctors & patients are saying about 'Beat Your A-Fib'.

Idarucizumab fda approval